|
Match
|
Document |
Document Title |
|
|
6086918 |
Oral peptide pharmaceutical products
|
|
|
6082368 |
Nicotine candy cigarette
A nicotine candy is provided for consumption in small volumes and in a cigarette shaped package. Each portion of the candy is obtained by removing it from a cigarette shaped package from the end....
|
|
|
6077540 |
Gelatin spray coating
This invention provides a coating composition in which the principal film former is gelatin for use in coating tablets. The gelatin coating may be used with tablets, with or without any subcoating,...
|
|
|
6056968 |
Pharmaceutical drug dosage forms providing different release rates
A pharmaceutical dosage form comprises, in one portion thereof, a substantially single (+)-enantiomer of a chiral drug other than verapamil and, in another, separate portion thereof, a...
|
|
|
6051255 |
Polymer coated tablet comprising amoxycillin and clavulanate
The present invention is to a tablet formulation, being a medicament for oral administration for the treatment of bacterial infections, the tablet comprising a compacted mixture of 750-950 mg of...
|
|
|
6039974 |
Pharmaceutical composition for combination of piperidinoalkanol-decongestant
The present invention provides a pharmaceutical composition in the form of a bilayer tablet comprising, (a) a first discrete zone made with Formulation (A) which comprises, a therapeutically...
|
|
|
6036976 |
Sustained release microspheres and preparation thereof
Disclosed is a method of producing microspheres which comprises subjecting a w/o/w emulsion or o/w emulsion to an in-water drying method under the following conditions: 1) the amount of...
|
|
|
6033685 |
Tablet for the controlled release of active agents
The present invention provides a tablet for the controlled release of an active agent comprising (a) a matrix layer comprising an active agent embedded in a non-swelling, non-gelling hydrophobic...
|
|
|
6025391 |
Enteric-coated pharmaceutical compositions of mycophenolate
|
|
|
6015577 |
Pharmaceutical compositions containing dipyridamole or mopidamol and acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing them and their use in treating clot formation
The specification describes a pharmaceutical combination consisting of dipyridamole or mopidamol and acetylsalicylic acid or the physiologically acceptable salts thereof, processes for preparing...
|
|
|
5997903 |
Oral-administration forms of a medicament containing pantoprazol
The invention relates to oral presentation forms for pantoprazole, which consist of a core, an intermediate layer and an outer layer which is resistant to gastric juice.
|
|
|
5997905 |
Preparation of pharmaceutically active particles
The present invention provides a core of predominately microcrystalline cellulose, on which an active drug is layered onto the core via solution coating. The coated particles have a narrower...
|
|
|
5989557 |
Process for extracting polyphenol fractions of tea and compositions produced therewith
The present invention relates to the preparation of novel polyphenol fractions of Camellia sinensis (tea), the use thereof and formulations containing them. The invention relates specifically to...
|
|
|
5985329 |
Particulate foods and pharmaceuticals coated with water-soluble hemicellulose
A coated product in the form of solid particles of a food or pharmaceutical wherein the particles are each coated with a water-soluble hemicellulose. The water-soluble hemicellulose has a viscosity...
|
|
|
5972383 |
Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
This invention provides orally administerable pharmaceutical formulations comprising raloxifene, its ethers or esters, or a pharmaceutically-acceptable salt thereof, in combination with a...
|
|
|
5968553 |
Pharmaceutical composition containing bupropion hydrochloride and an inorganic acid stabilizer
Novel, stable formulations of bupropion hydrochloride are provided which will maintain at least 80% of initial bupropion hydrochloride potency after one year. Methods of inhibiting degradation of...
|
|
|
5962024 |
Peroral composition for controlled release in the lower gastrointestinal tract
The invention relates to a peroral composition providing controlled release of a drug, the composition comprising a) a core comprising the drug and a drug release controlling agent and b) an...
|
|
|
5954958 |
Bacteriocidal dialysis collection bag
A method for manufacturing and using a dialysis collection bag, and the dialysis collection bag itself. A collection bag is fabricated with a sterilization tablet therein, having a soluble coating...
|
|
|
5952005 |
Controlled release preparation for administering morphine
An oral pharmaceutical preparation containing a therapeutically effective amount of a salt of morphine for administration once daily is provided. The preparation contains particles which have a...
|
|
|
5942248 |
Pharmaceutical composition containing a low detergent effect bile salt and an active compound that undergoes biliary excretion and/or enterohepatic recycling
Non-steroidal anti-inflammatory drugs, such as indomethacin, and other pharmaceutically active compounds, are formulated with bile acids or their salts and conjugates. Bile acids previously...
|
|
|
5922342 |
Lateral edge coated controlled release pharmaceutical compositions
The invention provides a controlled release composition comprising a compressed core containing a drug having two parallel planar surfaces (i.e. the top and bottom), and a seal coating surrounding...
|
|
|
5912014 |
Oral salmon calcitonin pharmaceutical products
Bioavailability of salmon calcitonin to be administered orally is enhanced by a pharmaceutical composition providing targeted release of the peptide to the intestine, together with an absorption...
|
|
|
5912268 |
Dosage form and method for treating incontinence
A composition comprising oxybutynin, a device comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
|
|
|
5908638 |
Pharmaceutical compositions of conjugated estrogens and methods for their use
This invention relates to novel pharmaceutical compositions and methods for their preparation containing conjugated estrogens for the treatment of peri-menopausal, menopausal and post-menopausal...
|
|
|
5895663 |
Pseudoephedrine hydrochloride extended-release tablets
Pseudoephedrine hydrochloride extended-release tablets including a sustained release hydroxypropylmethylcellulose matrix and a microcrystalline cellulose disintegrant formed by a dry mixed, direct...
|
|
|
5888545 |
Carbamazepine medicament with retarded active substance release
An oral administration carbamazepine medicament with a retarded active substance release is disclosed. An aqueous plasticised polymer dispersion is applied on carbamazepine crystals without causing...
|
|
|
5882707 |
Method of coating an edible substrate with sugar/syrup or sugarless solutions containing dry color concentrate
A dry color concentrate for use in coloring sugar/syrup solutions and sugarless syrup solutions used to coat confectionery forms, pharmaceutical tablets, and the like, comprises 1) a carbohydrate...
|
|
|
5879706 |
Valaciclovir tablets containing colloidal silicon dioxide
A tablet comprising at least 50% w/w valaciclovir and 0.05 to 3% w/w colloidal silicon dioxide in which the valaciclovir is present within granules of the tablets and the silicon dioxide, a...
|
|
|
5876757 |
Pharmaceutical composition for rapid thrombolytic therapy
A magnesium-taurine compound and its method of synthesis. The compound is synthesized by reacting taurine and magnesium in a 2:1 molar ratio. The resulting mixture is diluted with methanol and the...
|
|
|
5874108 |
Salt coated tablet
The invention provides a coated tablet, a coating composition and a method of film coating. The coating is particularly useful for pharmaceutical tablets. The coating composition is composed of an...
|
|
|
5869093 |
Treatment of immune diseases by oral administration of autoantigens
The invention is directed to a method of treating a T cell-mediated autoimmune disease in animals, including humans, by the oral administration of autoantigens, fragments of autoantigens, or...
|
|
|
5869094 |
Solid form of administration of isosorbide 5-mononitrate
A solid form of oral administration of isosorbide 5-mononitrate with a controlled, pH-independent release of the active substance in the gastro-intestinal tract is constituted by a pellet coated...
|
|
|
5869096 |
Oral osmotic device with hydrogel driving member
An osmotic device (10) for delivering a beneficial drug, such as an anti-fungal, into the mouth of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably...
|
|
|
5861173 |
Long-lasting release nifedipine preparation
This invention provides a long-lasting release solid nifedipine preparation which exhibits clinically sufficient effect when administered once per day. A press coated tablet whose core and shell...
|
|
|
5858364 |
Pharmaceutical dosage form for treatment of multiple sclerosis
The invention is directed to a method of treating a T cell-mediated autoimmune disease in animals, including humans, by the oral administration of autoantigens, fragments of autoantigens, or...
|
|
|
5853760 |
Device for the controlled release of active substances
A device for the controlled release of active substances in liquid media from an active substance-containing matrix exhibiting active substance releasing-surfaces has, the active substance...
|
|
|
5849327 |
Delivery of drugs to the lower gastrointestinal tract
Diseases of the colon are treated by oral ingestion of a unit dosage form containing a plurality of porous microscopic beads, the pores containing an active agent or drug and plugged with a...
|
|
|
5846569 |
Colostrum supplement
A consumable supplement contains a colostrum component composed of processed bovine colostrum, magnesium peroxide as a source of active oxygen, a vitamin such as vitamin C, magnesium succinate and...
|
|
|
5842476 |
Method for controlling fertility
An osmotic device is disclosed comprising an exterior coat comprising an estrogenic and a progestogenic steroid that are delivered immediately as a contraceptive pair for fertility regulation in a...
|
|
|
5840754 |
Dosage form comprising oxybutynin
A composition comprising oxybutynin, a device comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
|
|
|
5840333 |
Process for the preparation of oral compositions containing quinolones
Method for the preparation of an improved oral formulation of active ingredients belonging to the class of quinolones. The method is characterized by an intermediate compacting and grinding stage,...
|
|
|
5837291 |
Enteric preparation coated with a non-solvent enteric coating agent using a liquid plasticizer
An enteric preparation prepared by coating a solid dosage form with a fine powder enteric coating agent while spraying a liquid plasticizer.
|
|
|
5837285 |
Fast soluble tablet
The object of the present invention is to provide a tablet that dissolves rapidly in the oral cavity (fast soluble tablets) that can be produced by a simple method without special preparation...
|
|
|
5814339 |
Film coated tablet of paracetamol and domperidone
The present invention is concerned with a film coated tablet comprising as active ingredients the analgesic agent paracetamol and the antiemetic agent domperidone, and with a process of preparing...
|
|
|
5814336 |
Pharmaceutical dosage form for colonic delivery
The present invention relates to a pharmaceutical composition in a unit dosage form for peroral administration in a human or lower animal, having a gastrointestinal tract comprising a small...
|
|
|
5811121 |
PH-sensitive coatings based on cellulose acetoacetate
This invention is based on the discovery that certain cellulose acetoacetate mixed esters will remain insoluble in mild (near-neutral) or acidic aqueous solutions, but dissolve under alkaline...
|
|
|
5811388 |
Delivery of drugs to the lower GI tract
Pharmaceutical compositions for orally delivering a therapeutically effective amount of a drug to the colon without significant release of the drug in the upper GI tract after oral administration...
|
|
|
5807576 |
Rapidly dissolving tablet
The present invention comprises a tablet, and method for making such, which disintegrates or dissolves in a matter of just a few seconds once placed into the oral cavity. Generally, the method of...
|
|
|
5807578 |
Fast-melt tablet and method of making same
Provided is an improved, fast-melting solid dosage form which readily disintegrates when placed in the mouth. The solid dosage form preferably being a tablet comprising the following primary...
|
|
|
RE35893 |
Defoaming composition
A defoaming or antifoaming composition comprises a free flowing granular combinate of 50 to 90 weight percent of a water soluble carbohydrate-based agglomerate selected from the group consisting of...
|